Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$149M |
| 2 |
Verizon
VZ
|
+$106M |
| 3 |
WisdomTree Japan Hedged Equity Fund
DXJ
|
+$97.2M |
| 4 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$72.3M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$60.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$95.2M |
| 2 |
SDRL
Seadrill Limited Common Stock
SDRL
|
+$46.3M |
| 3 |
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
|
+$36.8M |
| 4 |
BP
BP
|
+$35.9M |
| 5 |
AstraZeneca
AZN
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.07% |
| 2 | Energy | 3.19% |
| 3 | Communication Services | 2.77% |
| 4 | Healthcare | 2.75% |
| 5 | Financials | 2.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
First Trust Dorsey Wright Focus 5 ETF
FV
$3.61B
| $4.39M | 0.05% |
+232,813
| New | +$4.5M |
|
277
EOG Resources
EOG
$77.1B
| $4.34M | 0.05% |
+44,278
| New | +$3.94M |
|
278
ProShares Short VIX Short-Term Futures ETF
SVXY
$221M
| $4.33M | 0.05% |
69,918
+14,172
| +25% | +$883K |
|
279
Invesco DB Agriculture Fund
DBA
$1.24B
| $4.3M | 0.05% |
151,659
-34,943
| -19% | -$917K |
|
280
Invesco Biotechnology & Genome ETF
PBE
$290M
| $4.29M | 0.05% |
+103,071
| New | +$4.41M |
|
281
CALL
ProShares UltraShort Energy
DUG
$21M
| $4.28M | 0.05% |
4,550
+3,970
| +684% | +$4.09M |
|
282
VanEck Junior Gold Miners ETF
GDXJ
$6.82B
| $4.28M | 0.05% |
118,150
+107,548
| +1,014% | +$4.14M |
|
283
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.9B
| $4.28M | 0.05% |
+132,244
| New | +$4.31M |
|
|
284
AstraZeneca
AZN
$270B
| $4.28M | 0.05% |
65,899
-505,236
| -88% | -$32.6M |
|
285
PUT
iShare MSCI Eurozone ETF
EZU
$9.38B
| $4.27M | 0.05% |
+101,000
| New | +$4.14M |
|
|
DCP
286
DELISTED
DCP Midstream, LP
DCP
| $4.26M | 0.05% |
85,128
+78,457
| +1,176% | +$3.88M |
|
287
W.P. Carey
WPC
$17.1B
| $4.26M | 0.05% |
+72,425
| New | +$4.38M |
|
288
Cemex
CX
$17B
| $4.21M | 0.05% |
390,384
+336,665
| +627% | +$3.63M |
|
289
Chevron
CVX
$382B
| $4.18M | 0.05% |
35,166
-75,641
| -68% | -$8.8M |
|
290
PUT
Direxion Daily Energy Bull 2X ETF
ERX
$233M
| $4.18M | 0.05% |
4,570
-11,040
| -71% | -$9.14M |
|
291
Eli Lilly
LLY
$1.09T
| $4.16M | 0.05% |
70,686
+64,085
| +971% | +$3.58M |
|
292
CALL
Vodafone
VOD
$37.2B
| $4.12M | 0.05% |
112,008
-89,097
| -44% | -$3.43M |
|
|
GAF
293
DELISTED
SPDR S&P Emerging Middle East & Africa ETF
GAF
| $4.11M | 0.05% |
58,628
-32,031
| -35% | -$2.09M |
|
|
HES
294
DELISTED
Hess
HES
| $4.09M | 0.05% |
49,392
+26,130
| +112% | +$2.08M |
|
295
WisdomTree Emerging Markets Local Debt Fund
ELD
$140M
| $4.09M | 0.05% |
+89,114
| New | +$4.01M |
|
|
CS
296
DELISTED
Credit Suisse Group
CS
| $4.08M | 0.05% |
126,068
+113,979
| +943% | +$3.57M |
|
|
297
PUT
ProShares UltraShort Energy
DUG
$21M
| $4.07M | 0.05% |
+4,320
| New | +$4.45M |
|
298
Cogent Communications
CCOI
$598M
| $4.05M | 0.04% |
+114,073
| New | +$4.46M |
|
|
QGENF
299
DELISTED
QIAGEN NV
QGENF
| $4.02M | 0.04% |
+190,601
| New | +$4.02M |
|
300
iShares Biotechnology ETF
IBB
$9.53B
| $4.02M | 0.04% |
+51,000
| New | +$4.25M |
|
Similar funds
Jane Street's Q1 2014 Portfolio in Review
As of Q1 2014, Jane Street held 3,508 positions worth $9.04B, up 29% from $6.99B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jane Street deployed $1.97B of net new capital in Q1 2014, opening 1,229 new positions and adding to 745 existing holdings. Its largest new stake was State Street SPDR S&P MIDCAP 400 ETF Trust: 608,516 shares worth $152M.
By sector, the portfolio is most concentrated in Technology at 4.1% of assets, down from 4.8% a quarter earlier, followed by Energy and Communication Services.
On the sell side, the largest reduction was Vanguard FTSE Emerging Markets ETF, an estimated $95.2M trimmed.
- Jane Street's largest Q1 2014 buy was State Street SPDR S&P MIDCAP 400 ETF Trust: 608,516 shares worth $152M.
- Jane Street added most to Verizon in Q1 2014, an estimated $106M increase.
- Jane Street's biggest Q1 2014 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $95.2M.
- Jane Street fully exited iShares MSCI Emerging Markets ETF in Q1 2014, selling an estimated $30.3M.
- Jane Street's ten largest holdings make up 29% of its $9.04B portfolio in Q1 2014.
- Jane Street opened 1,229 new positions and closed 870 in Q1 2014.
- Jane Street's portfolio value rose 29% quarter-over-quarter to $9.04B.
Based on Jane Street's 13F filing for Q1 2014, filed 15 May 2014.